Form 4: Verastem CEO Sells $60K in Stock via 10b5-1 Plan
Insider Transaction Report
Verastem Inc.'s President and CEO, Dan Paterson, sold 6,000 shares of common stock for $60,000 through a pre-arranged Rule 10b5-1 trading plan.
Summary
- Dan Paterson, who serves as President and CEO and a Director of Verastem, Inc. (VSTM), reported sales of the company's common stock.
- A total of 6,000 shares were sold across three separate transactions between November 21, 2025, and November 25, 2025.
- Each transaction involved the sale of 2,000 shares at a price of $10.00 per share.
- The aggregate value of the shares sold amounts to $60,000.
- These sales were executed pursuant to a pre-established Rule 10b5-1 trading plan.
- Following these transactions, Dan Paterson's direct beneficial ownership in Verastem common stock stands at 432,818 shares.
Sentiment
Score: 4
Explanation: The sale of shares by a key executive, even under a 10b5-1 plan, is generally viewed with caution by investors. While the plan indicates pre-planning and not necessarily a reaction to immediate news, it still represents a reduction in insider ownership, which can be perceived as a negative signal regarding future prospects or valuation.
Negatives
- Insider selling by a key executive (President and CEO) and Director, even under a Rule 10b5-1 plan, can be perceived negatively by the market, potentially signaling a lack of confidence or a desire to diversify holdings.
- The sale of 6,000 shares at $10.00 per share, totaling $60,000, represents a reduction in the CEO's direct ownership in the company.
Risks
- Potential negative market perception due to insider selling by a high-ranking executive.
- Reduced alignment of the CEO's personal financial interests with long-term shareholder value if selling continues or is substantial.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Plan | The reported sales were executed pursuant to a Rule 10b5-1 trading plan, which allows insiders to set up a pre-scheduled plan to buy or sell company stock to avoid accusations of insider trading. | Prior to 11/21/2025 (adoption date not specified, but transactions started 11/21/2025) | Enhances transparency and provides an affirmative defense against insider trading allegations, but the underlying action (selling) can still influence market perception. |
Stakeholder Impact
- Shareholders may interpret the CEO's stock sales as a signal regarding the company's future prospects or valuation, potentially leading to negative sentiment or selling pressure on the stock.
Key Dates
| Date | Description |
|---|---|
| 11/21/2025 | Sale of 2,000 shares of common stock at $10.00 per share. |
| 11/24/2025 | Sale of 2,000 shares of common stock at $10.00 per share. |
| 11/25/2025 | Sale of 2,000 shares of common stock at $10.00 per share. |
| 11/25/2025 | Form 4 filing date. |
Recommendation
holdWhile the CEO's sale of shares under a Rule 10b5-1 plan suggests a pre-planned diversification or liquidity event rather than a reaction to immediate negative news, it still represents a reduction in insider ownership. This can be a yellow flag for investors, prompting a 'hold' recommendation to observe future company performance and further insider activity before making a definitive 'buy' or 'sell' decision. The amount sold is not extremely large relative to total holdings, but the executive's position makes it notable.
Keywords
Verastem, VSTM, Dan Paterson, Insider Trading, Form 4, Stock Sale, CEO, 10b5-1 Plan, Equity Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.